SECTION 229.3. Fee

Latest Version
Updated Version

Latest version.

This subchapter applies to all prescription drug manufacturers reporting drug price information. A fee of $250 shall be submitted with each submitted annual report and price increase report.

Source Note: The provisions of this §229.3 adopted to be effective January 17, 2022, 47 TexReg 86

                    
                        var val = document.getElementById('citecontent').innerHTML;
                        art.dialog.defaults.title = window.location.href;
                        art.dialog.data('cite', val);
                        art.dialog.data('homeDemoPath', '/Scripts/plus/artDialog/');
                        art.dialog.open('/Scripts/plus/artDialog/citeiframe.html');